Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medcomm|July 6, 2026
Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision TherapyHanwen Hu, Zhixing Hao, Lili Li, et al.
Heliyon|April 1, 2024
Development and validation of a novel prognostic lncRNA signature based on the APOBEC3 family genes in gastric cancerJia Qi, Wenxuan Wu, Jing Chen, et al.
Cancer Immunology, Immunotherapy : CII|May 2, 2021
CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancerPin Wu, Lufeng Zhao, Yongyuan Chen, et al.
Frontiers in Pharmacology|December 12, 2022
NMI: a potential biomarker for tumor prognosis and immunotherapyTeng He, Yinbiao Qiao, Qi Yang, et al.
Nature Communications|September 17, 2022
The immune landscape of human thymic epithelial tumorsZhongwei Xin, Mingjie Lin, Zhixing Hao, et al.
European Journal of Immunology|October 7, 2022
Tissue-resident CD69<sup>+</sup> CXCR6<sup>+</sup> Natural Killer cells with exhausted phenotype accumulate in human non-small cell lung cancerXiaoke Chen, Yongyuan Chen, Zhongwei Xin, et al.
Cancer Letters|April 3, 2024
JAML promotes the antitumor role of tumor-resident CD8<sup>+</sup> T cells by facilitating their innate-like function in human lung cancerZhixing Hao, Zhongwei Xin, Yongyuan Chen, et al.
Oncoimmunology|July 8, 2022
Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activationTeng He, Zhixing Hao, Mingjie Lin, et al.
Cell Reports|February 14, 2024
Inflammatory dendritic cells restrain CD11b<sup>+</sup>CD4<sup>+</sup> CTLs via CD200R in human NSCLCMingjie Lin, Di Chen, Zheyu Shao, et al.
Frontiers in Immunology|February 4, 2022
Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung CancerZhixing Hao, Mingjie Lin, Feng Du, et al.
Pageof 2